Sign Up for Free!

Continue Analyzing the page and more.

Already have an Account? Log In

The Trial has ended

Continue Analyzing the page and more.

PANACEA LIFE SCIENCES HOLDINGS, INC. logo

PANACEA LIFE SCIENCES HOLDINGS, INC.

US$0.03

US$591300.0

-8.57%

-55.56%

Transparent research score

MaveScore

A research prioritization score from 0 to 100. It is model output for watchlist review, not personalized financial advice.

24 Low confidence High
Fundamentals Dec 31, 2024
Price Jun 09, 2026
Confidence High

Stored data quality

Freshness and coverage checks

Stored company inputs are available, but some dates or model fields are older or incomplete.

16/16 Partial or delayed snapshot
Fundamental period Dec 31, 2024 526 days old
Price snapshot Jun 09, 2026 1 day old
Input coverage 16/16 Stored fields powering this model output
Confidence impact 0 gaps Missing fields reduce confidence and can limit signal detail

Quality

Quality score blends the latest weighted model rank with underlying profitability and dilution ranks.

8/35 Weak

Financial Strength

Financial strength rewards durable profitability, margins, and positive free cash flow.

9/25 Weak

Valuation Support

Valuation favors positive earnings, positive cash flow, and lower price-to-book multiples.

5/15 Weak

Momentum

Momentum highlights research candidates with supportive 3-month and 6-month price regimes.

0/15 Weak

Shareholder Alignment

Shareholder alignment rewards less dilutive share behavior and enough size for liquid research coverage.

2/10 Weak

Positive model output

More live company inputs are needed before positive research signals can be surfaced.

Research risks to review

  • Quality score blends the latest weighted model rank with underlying profitability and dilution ranks.
  • Financial strength rewards durable profitability, margins, and positive free cash flow.
  • Valuation favors positive earnings, positive cash flow, and lower price-to-book multiples.

MaveScore uses historical model inputs, stored company fundamentals, and stored price context for research support only. Review missing inputs and business-specific risks before acting.

Dashboard Funda..tals Deep..lue Prediction Screener Map

PANACEA LIFE SCIENCES HOLDINGS, INC. Overview

Industry: Drug Manufacturers Specialty & Generic

Sector: Healthcare

Panacea Life Sciences Holdings, Inc., operates as a holding company, manufactures, research, and produces hemp-derived cannabinoid, functional mushroom, kratom, and nutraceutical products for consumers and pets. The company also involved in the white label and contract manufacturing sales to other cannabinoid companies, raw material sales, and tolling arrangements. In addition, it offers natural remedies for aspect of life under the PANA Health, PANA Beauty, PANA Sport, PANA Pet, PANA Pure, and PANA Life brand name. The company was incorporated in 2008 and is headquartered in Greenwood Village, Colorado.

PANACEA LIFE SCIENCES HOLDINGS, INC. is evaluated using Mavefund's quality framework: growing earnings, durable profit margins, conservative leverage, strong return on equity, and disciplined share repurchases.

Score

Price History & Performance

Review PANACEA LIFE SCIENCES HOLDINGS, INC. in context before unlocking the interactive price chart, financial overlays, and downloadable ratio tables.

Recent News



PANACEA LIFE SCIENCES HOLDINGS, INC. Competitors

PANACEA LIFE SCIENCES HOLDINGS, INC. operates in the Drug Manufacturers Specialty & Generic industry within the Healthcare sector. Unlock the full page to compare peer rankings, valuation quality, profitability, leverage, and growth trends.

Earnings Per Share

EPS quality is one of the core Mavefund signals. Sign up to continue into the detailed EPS, ROE, margin, share buyback, leverage, and financial ratio analysis.

Continue the analysis

Sign up to unlock ROE, net margin, share buyback, leverage, financial ratios, peer charts, and downloads.

View plans
Ticker Image

PANACEA LIFE SCIENCES HOLDINGS, INC.

US$0.03

US$591300.0

-8.57%

-55.56%